Results 131 to 140 of about 6,904 (161)

Use of inactivated poliovirus vaccine for poliovirus outbreak response

The Lancet Infectious Diseases
With continued wild poliovirus transmission in Afghanistan and Pakistan and circulating vaccine-derived poliovirus in certain countries, there exists an ongoing risk of importation of polioviruses into other countries, including those that have been polio-free for decades.
Ananda S, Bandyopadhyay, Rocio, Lopez Cavestany, Isobel M, Blake, Grace, Macklin, Laura, Cooper, Nicholas, Grassly, Ana Leticia Melquiades Dos Santos, Nery, Ondrej, Mach   +7 more
openaire   +2 more sources

Sequential Use of Inactivated Poliovirus Vaccine followed by Oral Poliovirus Vaccine in Oman

Journal of Infectious Diseases, 1997
Seroprevalence and geometric mean titers (GMTs) were compared at 6 and 10 months after vaccination with monovalent type 1 oral poliovirus vaccine (OPV) at 6 months and trivalent OPV at 7 and 9 months. Group 1 had received 4 doses of OPV, group 2 OPV at birth and 3 doses of OPV and inactivated poliovirus vaccine (IPV), and group 3 placebo at birth and 3
R W, Sutter, A J, Suleiman, P G, Malankar, F R, Mehta, M A, Medany, M A, Arif, R W, Linkins, M A, Pallansch, M S, El-Bualy, S E, Robertson   +9 more
openaire   +2 more sources

Poliovirus-specific immunoglobulin A in persons vaccinated with inactivated poliovirus vaccine in The Netherlands

Clinical Diagnostic Laboratory Immunology, 1997
In The Netherlands the inactivated poliovirus vaccine (IPV) is used for protection against poliomyelitis. It is not clear if parenteral vaccination with IPV can lead to priming of the mucosal immune system. We developed and evaluated enzyme-linked immunosorbent assays for the detection of poliovirus serotype-specific immunoglobulin A (IgA) and ...
Herremans, MMPT, van Loon, AM, Reimerink, JHJ, Rumke, HC, van der Avoort, HGAM, Kimman, TG, Koopmans, MPG   +6 more
openaire   +4 more sources

[Inactivated poliovirus vaccine].

Nihon rinsho. Japanese journal of clinical medicine, 2011
During the final stage of global polio eradication program, universal use of inactivated poliovirus vaccine (IPV) is the most feasible option to minimize the inherent risk of oral poliovirus vaccine (OPV), such as vaccine-associated paralytic poliomyelitis (VAPP) and polio outbreaks due to vaccine-derived polioviruses.
openaire   +1 more source

Inactivated Poliovirus Vaccine

Human Vaccines, 2007
Subhash C, Arya, Nirmala, Agarwal
openaire   +2 more sources

Inactivated poliovirus vaccine and the final stages of poliovirus eradication

Vaccine, 2001
The use of the inactivated poliovirus vaccine (IPV) will increase before and probably also after the global eradication of the wild type poliovirus. Before eradication, the switch from the use of oral poliovirus vaccine (OPV) to IPV has been due to the better safety record of IPV. Introduction of IPV in the regular immunisation schedules is made easier
openaire   +2 more sources

Poliovirus-vaccine-inactivated

Reactions Weekly, 2021
openaire   +1 more source

Mucosal immunity following oral poliovirus vaccine and enhanced potency inactivated poliovirus vaccine immunization

Pediatric Infectious Disease, 1991
Mucosal immunity is considered to be an important barrier for inhibiting person-to-person transmission of naturally occurring (wild type) poliovirus infection. This review briefly summarizes the results of a previously published study in which 79 oral poliovirus vaccine (OPV) vaccinated children and 93 enhanced-potency inactivated poliovirus vaccine ...
openaire   +2 more sources

Poliovirus Vaccine—Inactivated

2023
Emmanuel J. Vidor, John F. Modlin
openaire   +1 more source

Poliovirus Vaccine–Inactivated

Reactions Weekly, 2018
openaire   +2 more sources